年轻患者中心心置换:综述和当前的挑战
Fadi Hage1, Ali Hage1, Manuel R Cervetti1
1Division of Cardiac Surgery, Department of Surgery, Western University, London Health Sciences Centre, London, ON, Canada.
Future cardiology
|July 10, 2024
概括
中心门修复为门疾病提供了很好的生存率. 对于无法修复的病例,机械假肢可能会改善生存率,对于需要额头门置换的年轻患者,有更新的选择.
科学领域:
- 心血管外科心血管外科
- 生物材料科学 生物材料科学
- 临床结果研究研究
背景情况:
- 密特拉病的管理需要仔细考虑修复与更换.
- 假肢门的选择对患者的长期存活率和重新干预率产生重大影响.
研究的目的:
- 评估中膜修复和更换策略的长期结果.
- 为了比较机械与生物假肢在中枢置换中的疗效.
- 评估接受中枢置换的年轻患者和以前失败的跨导管中枢入手术的年轻患者的结果.
主要方法:
- 对接受 mitra 门修复的患者的生存数据进行比较分析.
- 审查与机械和生物假肢在中枢置换相关的结果.
- 评估之前进行了门干预的患者的重新手术率和结果.
主要成果:
- 中心门修复显示出优异的长期存活率,与一般人群相比.
- 机械假肢可能会比生物假肢提供更好的生存期,当米特拉的修复是不可行的.
- 年轻患者可能会从新的假体门技术中受益.
- 过导管 mitra 门-in-valve 失败后的 mitra 门手术与高死亡率和发病率有关.
结论:
- mitra 门修复仍然是对 mitra 门疾病的首选干预措施.
- 假肢门的选择至关重要,在某些情况下,机械选项可能更优越.
- 对年轻患者进行先进假肢的进一步研究是必要的.
- 高风险的结果需要小心地管理需要重新手术的患者后,失败的跨导管二手中在门.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


